Texas Tech's athletic department just announced a major rebrand on a random Tuesday in October.

Cyteph Pty Ltd, a biotechnology company developing novel immunotherapies for difficult-to-treat cancers, today announced that it has successfully completed recruitment for its first-in-human Phase I ...